Research Library

Repealing Obamacare and replacing it with market-based coverage that is both compassionate and prudent will make health care affordable again, which will guarantee access to insurance coverage for all Americans.

Science, technology, and innovation are vital to America’s economy and workforce, and the competitiveness of U.S. industry. The authors offer five recommendations to ensure the establishment of an effective White House Office of Science and Technology Policy.

Investing in child nutrition and alleviating child hunger in low-income settings are not only important from an ethics and equity perspective but also make economic sense, writes fellow Farhan Majid.

The United States has a unique opportunity to reduce the spread of disease by engaging the leaders of the G20 countries and targeting neglected diseases. Fellow Peter Hotez explains how.

With growing competition from abroad, the U.S. must reform its fiscal policy to reduce debt, maximize economic efficiency — including minimizing the distortions caused by the tax system — and maintain its areas of competitive advantage.

There is broad consensus in the medical and scientific community that substance abuse should be treated as a medical and public health problem, not a crime. The authors recommend a sensible pivot from failed policies of drug prohibition toward a realistic approach to drug use.

Has the quality of surgical care in the Veterans Health Administration improved over time?

Regardless of one’s views toward Fidel Castro, his strong impact on world history is undeniable, Latin America Initiative director Erika de la Garza writes in this post for the Baker Institute Blog.

Almost two-thirds of Texans ages 18 to 64 stayed insured with health care coverage during the past 12 months, according to a new report by Rice University’s Baker Institute for Public Policy and the Episcopal Health Foundation.

This policy brief analyzes the impact of the increasing number of parents who opt their children out of school-entry vaccinations for nonmedical reasons in Texas and argues that the state should make obtaining nonmedical exemptions more rigorous in order to reduce the public health risks and costs associated with vaccine-preventable diseases.